2269/N fundamentals
An in-depth look to WUXI BIOLOGICS (CAYMAN) INC operating, investing, and financing activities
2269/N free cash flow for H2 23 is 654.01 M MXN. For 2023, 2269/N free cash flow was 1.08 B MXN and operating cash flow was 11.22 B MXN.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
TTM